Recently, "Huafukang", China's first inactivated vaccine (Type 1, NM01 strain) for bovine viral diarrhea / mucosal diseases independently developed by Huaweite (Jiangsu) Bio-pharmaceutical Co., Ltd. ( Huaweite), an enterprise settled in CMC, was officially launched with the approval of the Ministry of Agriculture. The approval document No. is SYSZ 101453015.
Bovine viral diarrhea is an acute febrile infectious disease caused by bovine viral diarrhea virus, characterized by fever, leukopenia, mucosal erosion and ulcer, diarrhea or cough. The disease can seriously damage the bovine immune system, causing overall immunosuppression. And the resulting secondary infection is a main cause of non-pregnancy and abortion of cows, and high disease incidence and high mortality of calves. Bovine viral diarrhea has caused incalculable economic losses to the global cattle industry. It has been listed as a reportable epidemic disease by the World Organization for Animal Health. Before this, our country does not have a product for this disease.
Huaweite has successfully developed China's first inactivated vaccine for bovine viral diarrhea by screening strains, optimizing culture techniques and improving inactivation techniques. The technical performance of this product has reached the level of international similar products and it has filled a gap in the epidemic prevention of bovine diseases in china. This product can completely prevent diseases caused by bovine viral diarrhea virus. Clinical trial results show that the vaccine can effectively reduce the cow abortion rate, decrease diarrhea and respiratory diseases in calves to improve their survival rate, and reduce disease burden and promote the growth of beef cattle. The vaccine lasts up to 12 months.